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Saudi Arabia has witnessed gigantic progress in solcioeconomic development over the last 30 years. The government has committed vast resources to 
improving medical care for its citizens. The country has 
earned the 26th position in the WHO ranking of the 
world’s healthcare systems.1
Worldwide, Parkin et al estimated that there were 
10.9 million new cancer cases, 6.7 million deaths, and 
24.6 million persons living with cancer in the year 
2002,2 and the rates could further increase by 50% to 15 
million new cases in the year 2020. The predicted sharp 
increase in new cases is mainly attributed to steadily 
ageing populations in both developed and developing 
countries and to current trends in smoking prevalence 
and other unhealthy lifestyles. The population of Saudi 
Arabia as of July 2007 was estimated to be 27 million inl
cluding approximately six million resident expatriates.3 
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BACKGROUnD AnD OBJeCTIVeS: despite the low cancer incidence in saudi arabia, the country must be 
ready to face the challenge of a foreseeable increase in cancer burden mainly attributed to the growth and 
aging of the population. We designed this study to estimate the future cancer burden and to highlight the de-
mands on prospective healthcare resources. 
MeThODS: cancer statistics in saudi arabia from 2000 to 2004 were examined. the Joinpoint regression 
program was used to identify changes in secular trends, while the Globocan 2002 software projected fu-
ture burden. considering current trends and the growth and aging of the population, we projected the future 
burden.
ReSULTS: in 2004, the age-standardized rate (asr) for incidence for all cancer sites, excluding basal and squa-
mous skin cancer, was 57.2 per 100 000 (55.8 and 59.1 per in males and females, respectively). asr trends 
showed a statistically significant increase in the annual percent change (apc) for both males and females, 
which was greatest from 2003 to 2004 (4.93% and 2.64%, respectively). by the year 2020 and 2030, there 
would be an approximately 6- and 10-fold rise among males as compared with the burden in 2004. the cor-
responding numbers for females would be 5- and 8-fold, respectively. the highest cancer burden would be 
expected for middle-aged and elderly saudis.
COnCLUSIOnS: in countries currently experiencing low cancer rates, the future cancer burden could increase 
considerably and place enormous demands on healthcare resources. the present study may provide an impetus 
to examine the future all or site-specific cancer burden, particularly in developing countries.
Currently, half the Saudi population is under the age of 
20 years. The Saudi Arabia National Cancer Registry 
(NCR), a populationlbased registry, commenced rel
porting cancer in January 1994. In the latest report of 
the NCR for the year 2004, the total number of new 
cancer cases for Saudis was 6969, with an almost equal 
number for men and women. In the same year, 49% of 
male patients and 33% of female patients older than 59 
years of age were diagnosed with cancer, while that age 
group accounts for only 3.5% of the total Saudi populal
tion. Among Saudi patients, the agelstandardized rate 
(ASR) for incidence for all cancer sites excluding other 
skin cancers (International Classification of Disease 
version 10, C44) was 57.2 per 100 000 (55.8 and 59.1 
for males and females, respectively). The median age at 
diagnosis was 54 and 49 years for men and women, rel
spectively. While the ASR for cancer in Saudi Arabia 
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is among the lowest in the world, we postulate that the 
rates will significantly increase in the coming decades. 
While current cancer care programs in the country may 
be adequate, enormous additional resources will be rel
quired to meet this future increase in cancer incidence. 
To enable policymakers planning to meet future chall
lenges, we examined the current and predicted future 
cancer burden in the country. This model would also be 
useful for other developing countries. 
MeThODS
To compensate for variations in the agelstructure of 
different populations, ASR allows estimating rates a 
population would have if it had a standard age structure. 
The most frequently used standard for international 
comparisons is the World Standard Population 2000.4 
This is a hypothetical population of 100 000 grouped 
according to fivelyear age intervals. ASRs for all cancer 
sites in Saudi Arabia (excluding other skin sites, C44) 
were calculated from the NCR database adjusted for the 
WSP 2000. To use the most reliable and stable data for 
our model, we elected to analyze the most recent data 
(2000l2004). SEER’s Joinpoint regression program was 
used to identify changes in secular trend and to deterl
mine whether apparent changes in trend data are statistil
cally significant (twolsided, P<.05).5 The software takes 
the annual rate data and fits a series of joined straight 
lines on a log scale to the trends in rates. The tests of 
significance use a Monte Carlo permutation method. In 
this report, the resultant trends for varying time periods 
were described by annual percentage change (APC).
To predict cancer incidence in Saudi Arabia, we 
used the GLOBOCAN database and software.6 The 
GLOBOCAN software allows predicting future inl
cidence or mortality of various cancer types at 5lyear 
intervals, it also estimates population of countries (by 
age and sex) using the United Nations population prol
jections (the 2006 revision).7 The prediction requires 
an assignment of an appropriate APC for each of the 
predefined five age groups (0l14, 15l44, 45l54, 55l64, 
and 65+ years) for either males or females. This means 
that the cancer rates are assumed to change at a constant 
percentage of the rate of the previous year. Rates that 
change at a constant percentage every year change linl
Table 1. age-standardized rate for all cancer sites excluding basal and squamous skin cancer in Saudi arabia (2000-2004).
Age 
group
Age-standardized rate
2000 2001 2002 2003 2004
Total M F Total M F Total M F Total M F Total M F
0-4 0.88 0.95 0.81 0.75 0.74 0.77 0.67 0.64 0.69 0.74 0.80 0.67 0.88 0.87 0.88
5-9 0.55 0.54 0.57 0.44 0.55 0.33 0.46 0.55 0.37 0.44 0.51 0.37 0.44 0.49 0.38
10-14 0.51 0.50 0.53 0.47 0.55 0.39 0.45 0.50 0.40 0.51 0.55 0.47 0.52 0.60 0.44
15-19 0.78 0.89 0.67 0.84 0.89 0.78 0.76 0.69 0.83 0.78 0.70 0.87 0.86 0.89 0.81
20-24 0.56 0.43 0.74 0.61 0.47 0.81 0.54 0.37 0.78 0.70 0.52 0.93 0.73 0.59 0.91
25-29 0.53 0.32 0.90 0.56 0.34 0.93 0.56 0.37 0.86 0.60 0.44 0.87 0.63 0.45 0.91
30-34 0.67 0.35 1.19 0.57 0.38 0.88 0.57 0.34 0.93 0.65 0.35 1.15 0.65 0.37 1.11
35-39 1.18 0.58 2.13 1.21 0.67 2.07 1.05 0.56 1.81 1.17 0.75 1.82 1.28 0.75 2.08
40-44 2.43 1.55 3.61 2.28 1.54 3.24 2.31 1.40 3.48 2.52 1.56 3.75 2.61 1.56 3.94
45-49 3.71 2.42 5.29 3.55 2.53 4.77 4.34 3.03 5.85 4.60 3.27 6.10 4.86 3.71 6.14
50-54 4.76 3.72 6.00 4.90 4.05 5.87 4.59 3.97 5.28 5.68 4.91 6.52 5.74 4.84 6.70
55-59 5.49 4.55 6.63 5.22 4.95 5.53 5.79 5.16 6.51 6.34 5.92 6.80 5.75 5.02 6.55
60-64 8.62 8.10 9.25 8.09 7.93 8.28 8.39 8.38 8.39 8.94 8.73 9.19 10.19 10.25 10.12
65-69 7.36 7.89 6.69 5.55 4.57 6.75 7.08 7.70 6.34 7.63 8.31 6.85 7.93 8.92 6.80
70-74 5.92 6.91 4.57 5.93 6.53 5.13 6.01 7.02 4.69 6.57 7.20 5.78 6.28 6.83 5.63
75+ 7.31 9.04 5.23 6.77 8.16 5.08 7.99 9.30 6.40 7.15 8.60 5.40 7.81 9.62 5.65
Total 51.26 48.72 54.80 47.75 44.85 51.62 51.53 50.00 53.59 55.04 53.14 57.53 57.16 55.76 59.05
m: male, F: female
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early on a log scale. Based on the ASR for each age group 
of cancer patients in Saudi Arabia (2000l2004), we call
culated the log changes from one year to the next. The 
standard deviation of the changes per each group was 
then estimated and multiplied by the square root of the 
number of years (5 years) and the results represented 
the APC that we have used to estimate future cancer 
incidence for each age group.8 
ReSULTS
Table 1 shows the incidence of all cancer sites as ASR 
for various age groups for both genders. While it appears 
that ASRs were more or less stable over the examined 
period, fitting the trends revealed a significantly changl
ing pattern. Figures 1, 2 and 3 depict the ASR fitting of 
trends using Joinpoint software for all patients, males, 
and females, respectively. The corresponding APC for 
the last segment (2003l2004) was 3.85, 4.93 and 2.64, 
respectively, while the corresponding average APC for 
the entire period (2000l2004) was 2.8, 3.5, and 1.9, rel
spectively. The model indicated that all the changes that 
have occurred in recent years (2003l2004), or those esl
timated for the entire period (2000l2004) were statistil
cally significant from zero. 
 According to the US Census Bureau International 
Data Base, by the year 2010, 2020 and 2030 the total 
Saudi population is expected to be 30, 33 and 38 mill
lion, respectively.9 Moreover, the median age of Saudis 
is expected to increase from the current 21 years to 
22.5, and 25 years in 2020, and 2030, respectively. It 
is to be noted that the GLOBOCAN incidence data 
for cancer incidence in Saudi Arabia is slightly higher 
than that reported by the NCR, as data were correctl
ed for potential underl and delayedlreporting, besides 
adjustments made against rates in nearby regions. To 
predict future cancer burden, we used an APC for each 
age group (Table 2) calculated according to the method 
alluded to earlier.8 Table 3 demonstrates the expected 
increase in the total number of new cancer patients. By 
the year 2020 and 2030, there would be approximately 
a sixl and tenlfold rise among males as compared with 
the burden in 2004. The corresponding number for fel
males would be fivel and eightlfold, respectively. As anl
ticipated, the highest cancer burden would be expected 
for middlelaged and elderly Saudis.
DISCUSSIOn
The ASR for cancer in the Saudi Arabia is among the 
lowest in the world. While mere observation of current 
trends may imply that the rates are more or less stable, 
using more robust analysis proved otherwise. Fitting the 
ASR trends indicated a statistically significant increase 
Figure 1. Fitting the age-standardized rate for all cancer patients in Saudi arabia 
(2000-2004) according to the Joinpoint regression model. The legend shows the annual 
percent change for each segment.
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Figure 2. Fitting the age-standardized rate for male cancer patients in Saudi arabia 
(2000-2004) according to the Joinpoint regression model. The legend shows the annual 
percent change for each segment.
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Table 2. annual percent changes used in predicting future 
cancer burden.
Age group
(in years)
Annual percent change
Both genders Males Females
0-14 1.15 1.16 1.42
15-44 0.52 0.71 0.46
45-54 0.64 0.52 0.81
55-64 0.21 0.61 0.21
65+ 0.91 1.55 1.07
Figure 3. Fitting the age-standardized rate for female cancer patients in Saudi arabia 
(2000-2004) according to the Joinpoint regression model. The legend shows the annual 
percent change for each segment.
Table 3. predicted future new cancer patients for all sites excluding other skin cancer in Saudi arabia (2020 and 2030).
 No. of new patients (males) No. of new patients (females)
Age group 2004 2020 Changes % 2030 Changes % 2004 2020 Changes % 2030 Changes %
 0-14 320 959 300% 1,111 347% 267 758 284% 900 337%
15-44 740.00 2,977 402% 3,830 518% 1,135 4,086 360% 5,165 455%
45-54 447.00 3,306 740% 3,902 873% 624 4,060 651% 6,106 979%
55-64 615.00 5,309 863% 8,499 1382% 616 3,734 606% 5,618 912%
65+ 1,220.00 8,432 691% 17,376 1424% 724 4,684 647% 9,301 1285%
all ages 3,342.00 20,983 628% 34,717 1039% 3,366 17,323 515% 27,089 805%
in the APC for both males and females, which was 
more significant from 2003 to 2004 (4.93% and 2.64%, 
respectively). According to the Joinpoint estimates, we 
expect that the incidence of new cases will significantly 
increase in the coming few decades. The natural growth 
and aging of the population would be the main attributl
able factor for such increase.9
In addition to the demographic changes that would 
promote a greater cancer incidence, additional social and 
lifestyle factors would certainly contribute to a future 
increase. For instance, a recently published survey deml
onstrated a significant increase in age at first pregnancy 
and at marriage and a decrease in the parity rate.10 These 
changes would minimize the protective effect of these 
reproductive variables on the incidence of breast canl
cer, which is the most common among Saudi females. 
In addition, it was recently shown that the country is 
witnessing a high prevalence of physical inactivity,11 and 
an alarming increase in obesity.12,13 Furthermore, Saudis 
are embracing westernized nutritional habits more 
than ever before.14,15 Finally, the prevalence of smokl
ing in Saudi Arabia and other neighboring countries is 
showing a significant rise.16 The predicted substantial 
increase in cancer burden over the coming few decades 
should serve as a public motivation to modify some of 
the social changes and to battle unhealthy lifestyles that 
are currently prevalent in the country. 
Furthermore, an increased future cancer burden 
should alert policymakers about future demands on 
healthcare resources to meet such challenges. In Saudi 
Arabia, healthcare personnel number approximately 
180 000 and they are mainly expatriates.17 Saudis conl
stituted 20% of the total number of physicians and 27% 
of nurses. In 2002, the healthlworkerlperlpopulation 
ratio was 15 physicians per 10 000,18 which compares 
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favorably with the WHO minimum recommendation 
of one physician per 10 000 population for developl
ing countries, and the WHO Eastern Mediterranean 
Region average of 9.4 physicians per 10 000 populal
tion.19 However, the future expected increase in canl
cer burden as demonstrated in the model mandates 
visionary strategic plans. A shortage in the oncology 
work force is a worldwide predicament. The aging and 
growing population, with increasing numbers of cancer 
survivors and a slower growth in the supply of oncolol
gists will result in a significant shortage of medical and 
gynecologic oncologists in the USA by 2020.20 A shortl
age in oncological surgeons, radiation oncologists and 
nurses also exists.21l24 In British Columbia, patients ofl
ten wait 6 to 8 weeks for an initial assessment and up 
to 10 weeks after that for treatment.25 Lack of resources 
and basic infrastructure worldwide means that millions 
of people worldwide have no access to cancer screening, 
early diagnosis, treatment or palliative care.26 Moreover, 
the rising cost of oncology care, particularly for pharmal
ceuticals, is becoming a formidable hindrance.27
To face the future shortage in resources in oncoll
ogy practice in the USA, a study was commissioned by 
the American Society of Clinical Oncology. The study 
indicated that the most highly rated recommendations 
were reducing paperwork and regulations, and improvl
ing efficiency through information technology such 
as electronic medical records.20 Facing the prospect of 
work force shortages by training more physicians and 
nurses is not always easily attainable and cannot be recl
ommended as the sole plausible strategy. Authorities in 
Saudi Arabia should embrace the concept of training a 
sufficient number of nurse practitioners and physician 
assistants. We should carefully study the costleffectivel
ness of cancer preventive programs against the expected 
future cancer rise. Family physicians may take more rel
sponsibility in early detection programs and they should 
be more proactive in followinglup cancer patients after 
transferring care back from oncology facilities.28 
We conclude that Saudi Arabia will encounter a 
significant increase in future cancer burden and will rel
quire enormous healthcare resources. Perhaps the sinl
gle greatest opportunity to improve health and reduce 
deaths lies in personal behavior. In fact, behavioral facl
tors account for nearly 40% of all deaths in the USA.29 
Battling obesity, physical inactivity, smoking, and poll
luted air and water should be a top national priority in 
the war against cancer and other health problems. 
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